JP2013526497A5 - - Google Patents

Download PDF

Info

Publication number
JP2013526497A5
JP2013526497A5 JP2013509505A JP2013509505A JP2013526497A5 JP 2013526497 A5 JP2013526497 A5 JP 2013526497A5 JP 2013509505 A JP2013509505 A JP 2013509505A JP 2013509505 A JP2013509505 A JP 2013509505A JP 2013526497 A5 JP2013526497 A5 JP 2013526497A5
Authority
JP
Japan
Prior art keywords
formula
salt
solvate
diyl
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013509505A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013526497A (ja
JP5727002B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/057021 external-priority patent/WO2011141326A1/de
Publication of JP2013526497A publication Critical patent/JP2013526497A/ja
Publication of JP2013526497A5 publication Critical patent/JP2013526497A5/ja
Application granted granted Critical
Publication of JP5727002B2 publication Critical patent/JP5727002B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013509505A 2010-05-08 2011-05-03 置換ヘテロサイクリルベンジルピラゾール類およびその使用 Expired - Fee Related JP5727002B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10004855 2010-05-08
EP10004855.2 2010-05-08
PCT/EP2011/057021 WO2011141326A1 (de) 2010-05-08 2011-05-03 Substituierte heterocyclylbenzyl-pyrazole und ihre verwendung

Publications (3)

Publication Number Publication Date
JP2013526497A JP2013526497A (ja) 2013-06-24
JP2013526497A5 true JP2013526497A5 (OSRAM) 2014-06-26
JP5727002B2 JP5727002B2 (ja) 2015-06-03

Family

ID=44063276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013509505A Expired - Fee Related JP5727002B2 (ja) 2010-05-08 2011-05-03 置換ヘテロサイクリルベンジルピラゾール類およびその使用

Country Status (26)

Country Link
US (2) US20130172311A1 (OSRAM)
EP (1) EP2569312B1 (OSRAM)
JP (1) JP5727002B2 (OSRAM)
KR (1) KR20130108997A (OSRAM)
CN (1) CN103003269B (OSRAM)
AR (1) AR081368A1 (OSRAM)
AU (1) AU2011252223A1 (OSRAM)
BR (1) BR112012028651A2 (OSRAM)
CA (1) CA2798375A1 (OSRAM)
CO (1) CO6640218A2 (OSRAM)
CR (1) CR20120570A (OSRAM)
CU (1) CU20120157A7 (OSRAM)
DO (1) DOP2012000284A (OSRAM)
EA (1) EA201291167A1 (OSRAM)
EC (1) ECSP12012288A (OSRAM)
ES (1) ES2462522T3 (OSRAM)
IL (1) IL222851A0 (OSRAM)
MA (1) MA34939B1 (OSRAM)
MX (1) MX2012012960A (OSRAM)
PE (1) PE20130228A1 (OSRAM)
PH (1) PH12012502202A1 (OSRAM)
SG (1) SG185459A1 (OSRAM)
TN (1) TN2012000531A1 (OSRAM)
TW (1) TW201200510A (OSRAM)
UY (1) UY33369A (OSRAM)
WO (1) WO2011141326A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5603232B2 (ja) * 2007-05-01 2014-10-08 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ネコ類において骨関節炎を診断するための方法および組成物
US8796253B2 (en) * 2007-05-18 2014-08-05 Bayer Intellectual Property Gmbh Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
BR112012028651A2 (pt) * 2010-05-08 2016-08-09 Bayer Ip Gmbh heterociclilbenzilpirazóis substituídos e uso do mesmo
ES2782509T3 (es) 2012-07-02 2020-09-15 Monsanto Technology Llc Procedimiento para la preparación de 1,2,4-oxadiazoles 3,5-disustituidos
CA2882306A1 (en) 2012-08-24 2014-02-27 Board Of Regents, The University Of Texas System Heterocyclic modulators of hif activity for treatment of disease
EP2888256A4 (en) * 2012-08-24 2016-02-17 Univ Texas HETEROCYCLIC HIF ACTIVITY MODULATORS FOR THE TREATMENT OF DISEASES
WO2014031933A2 (en) * 2012-08-24 2014-02-27 Philip Jones Heterocyclic modulators of hif activity for treatment of disease
ES2726648T3 (es) 2014-02-25 2019-10-08 Univ Texas Sales de moduladores heterocíclicos de la actividad del HIF para el tratamiento de enfermedades
US10191597B2 (en) 2015-06-30 2019-01-29 Synaptics Incorporated Modulating a reference voltage to preform capacitive sensing
KR102544307B1 (ko) * 2017-01-13 2023-06-15 닛산 가가쿠 가부시키가이샤 방향족 디아민 화합물 전구체의 제조 방법
CN115944626B (zh) * 2022-12-08 2024-04-19 桂林医学院附属医院 小分子化合物在制备抗缺氧或缺血再灌注损伤药物中的应用
WO2025096658A1 (en) * 2023-10-30 2025-05-08 Pretzel Therapeutics, Inc. Compositions and inhibitors of polrmt

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610726B2 (en) * 2001-06-29 2003-08-26 North Shore-Long Island Jewish Research Institute Compositions and agents for modulating cellular proliferation and angiogenesis
CA2520870A1 (en) 2003-04-03 2004-10-21 Merck & Co., Inc. Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5
JP4499721B2 (ja) 2003-06-30 2010-07-07 ヒフ バイオ，インク． 化合物、組成物および方法
CN1842332A (zh) * 2003-06-30 2006-10-04 Hif生物公司 化合物、组合物及方法
GB0508472D0 (en) * 2005-04-26 2005-06-01 Glaxo Group Ltd Compounds
WO2007065010A2 (en) 2005-12-02 2007-06-07 Hif Bio, Inc. Anti-angiogenesis compounds
US8796253B2 (en) * 2007-05-18 2014-08-05 Bayer Intellectual Property Gmbh Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
DE102008057344A1 (de) * 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Aminoalkyl-substituierte Aryl-Verbindungen und ihre Verwendung
EA022271B1 (ru) * 2008-11-14 2015-12-30 Байер Интеллектуэль Проперти Гмбх Гетероциклические замещенные соединения арила в качестве ингибиторов hif
KR20110082570A (ko) * 2008-11-14 2011-07-19 바이엘 쉐링 파마 악티엔게젤샤프트 Ｈｉｆ 억제제로서 사용하기 위한 헤테로방향족 화합물
EP2202232A1 (en) 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
ES2405054T3 (es) 2009-01-23 2013-05-30 Bristol-Myers Squibb Company Derivados de pirazol-1,2,4-oxadiazol como agonistas de esfingosina-1-fosfato
BR112012028651A2 (pt) * 2010-05-08 2016-08-09 Bayer Ip Gmbh heterociclilbenzilpirazóis substituídos e uso do mesmo

Similar Documents

Publication Publication Date Title
JP2013526497A5 (OSRAM)
JP2010523476A5 (OSRAM)
JP2015517579A5 (OSRAM)
JP2017521457A5 (OSRAM)
JP2010500293A5 (OSRAM)
JP2019528276A5 (OSRAM)
JP2011529054A5 (OSRAM)
JP2013523896A5 (OSRAM)
JP2016500661A5 (OSRAM)
JP2011504903A5 (OSRAM)
JP2019524883A5 (OSRAM)
JP2011137006A5 (OSRAM)
JP6595078B2 (ja) アミノカルボニルカルバメート化合物
JP2013530150A5 (OSRAM)
JP2012513481A5 (OSRAM)
JP2016528273A5 (OSRAM)
RS53710B2 (sr) Jedinjenja kao antagonisti b1 bradikinina
JP2020520946A5 (OSRAM)
JP2013533253A5 (OSRAM)
JP2013512277A5 (OSRAM)
JP2016531126A5 (OSRAM)
JP2013511556A5 (OSRAM)
JP2010522710A5 (OSRAM)
RU2016151420A (ru) Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий
JP2014505017A5 (OSRAM)